Aortic Stenosis Device Improves Valve Hemodynamics
By HospiMedica International staff writers Posted on 21 May 2019 |
Image: The Leaflex Performer catheter (Photo courtesy of Pi-Cardia).
A novel catheter-based device mechanically scores calcifications at multiple locations on the aortic valve, restoring leaflet flexibility.
The Pi-Cardia (Rehovot, Israel) Leaflex Performer catheter is a transfemoral catheter that uses two unique mechanical structures for scoring valve calcifications. The deflectable transfemoral delivery catheter is inserted via a 16Fr sheath, positioned in the aortic root using fluoroscopic guidance. The device consists of a proprietary expander placed in the left ventricular outflow tract that lifts the aortic leaflets into contact with three scoring arms. The distal tip also features an atraumatic pigtail for safe positioning in the left ventricle, and also allows for monitoring of left ventricular pressure.
Mechanical expansion yields directed scoring of calcifications within the leaflets, and rotation of the arms allows scoring to be performed at different sections of each aortic valve leaflet. The scoring lines disrupt calcium deposits, creating multiple targeted fractures at optimal locations of valve calcification, causing them to separate. The unique scoring method helps to regain leaflets flexibility while preserving native valve integrity, thus providing a durable treatment option. It also serves as a preparatory step for improving the outcome of future valve implantation in heavily calcified and bicuspid aortic valves.
The design of the device is based on extensive clinical research on calcium growth patterns in thousands of human aortic valves, resulting in a mechanism of action and curative technology fundamentally different from traditional balloon aortic valvuloplasty, whereby the annulus and supporting anatomy are simply stretched to yield short-term hemodynamic improvement. In addition, since the valve remains patent, it does not preclude future transcatheter aortic valve replacement (TAVR), if the need arises. The device is currently undergoing first-in-human studies in Europe.
“As much as TAVR improves and becomes a routine procedure in lower surgical risk patients, it is still an implant with unknown durability, so there are many cases where taking this new approach of aortic valve repair to defer TAVR may make a lot of sense,” said Erez Golan, Founder and CEO of Pi-Cardia. “TAVR is also an expensive procedure, which restricts its use to specific centers and specific cases. In today's budget sensitive environment, waiting lists for TAVR are common even in the most developed countries, let alone in emerging markets, where TAVR may not be a viable option for most patients.”
Related Links:
Pi-Cardia
The Pi-Cardia (Rehovot, Israel) Leaflex Performer catheter is a transfemoral catheter that uses two unique mechanical structures for scoring valve calcifications. The deflectable transfemoral delivery catheter is inserted via a 16Fr sheath, positioned in the aortic root using fluoroscopic guidance. The device consists of a proprietary expander placed in the left ventricular outflow tract that lifts the aortic leaflets into contact with three scoring arms. The distal tip also features an atraumatic pigtail for safe positioning in the left ventricle, and also allows for monitoring of left ventricular pressure.
Mechanical expansion yields directed scoring of calcifications within the leaflets, and rotation of the arms allows scoring to be performed at different sections of each aortic valve leaflet. The scoring lines disrupt calcium deposits, creating multiple targeted fractures at optimal locations of valve calcification, causing them to separate. The unique scoring method helps to regain leaflets flexibility while preserving native valve integrity, thus providing a durable treatment option. It also serves as a preparatory step for improving the outcome of future valve implantation in heavily calcified and bicuspid aortic valves.
The design of the device is based on extensive clinical research on calcium growth patterns in thousands of human aortic valves, resulting in a mechanism of action and curative technology fundamentally different from traditional balloon aortic valvuloplasty, whereby the annulus and supporting anatomy are simply stretched to yield short-term hemodynamic improvement. In addition, since the valve remains patent, it does not preclude future transcatheter aortic valve replacement (TAVR), if the need arises. The device is currently undergoing first-in-human studies in Europe.
“As much as TAVR improves and becomes a routine procedure in lower surgical risk patients, it is still an implant with unknown durability, so there are many cases where taking this new approach of aortic valve repair to defer TAVR may make a lot of sense,” said Erez Golan, Founder and CEO of Pi-Cardia. “TAVR is also an expensive procedure, which restricts its use to specific centers and specific cases. In today's budget sensitive environment, waiting lists for TAVR are common even in the most developed countries, let alone in emerging markets, where TAVR may not be a viable option for most patients.”
Related Links:
Pi-Cardia
Latest Surgical Techniques News
- Miniaturized Implantable Multi-Sensors Device to Monitor Vessels Health
- Tiny Robots Made Out Of Carbon Could Conduct Colonoscopy, Pelvic Exam or Blood Test
- Miniaturized Ultrasonic Scalpel Enables Faster and Safer Robotic-Assisted Surgery
- AI Assisted Reading Tool for Small Bowel Video Capsule Endoscopy Detects More Lesions
- First-Ever Contact Force Pulsed Field Ablation System to Transform Treatment of Ventricular Arrhythmias
- Caterpillar Robot with Built-In Steering System Crawls Easily Through Loops and Bends
- Tiny Wraparound Electronic Implants to Revolutionize Treatment of Spinal Cord Injuries
- Small, Implantable Cardiac Pump to Help Children Awaiting Heart Transplant
- Gastrointestinal Imaging Capsule a Game-Changer in Esophagus Surveillance and Treatment
- World’s Smallest Laser Probe for Brain Procedures Facilitates Ablation of Full Range of Targets
- Artificial Intelligence Broadens Diagnostic Abilities of Conventional Coronary Angiography
- AI-Powered Surgical Visualization Tool Supports Surgeons' Visual Recognition in Real Time
- Cutting-Edge Robotic Bronchial Endoscopic System Provides Prompt Intervention during Emergencies
- Handheld Device for Fluorescence-Guided Surgery a Game Changer for Removal of High-Grade Glioma Brain Tumors
- Porous Gel Sponge Facilitates Rapid Hemostasis and Wound Healing
- Novel Rigid Endoscope System Enables Deep Tissue Imaging During Surgery